| 659688 |
CANCER MANAGEMENT AND RESEARCH |
Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib |
2021-03-01 |
10.2147/cmar.s292730 |
Facchinetti Francesco, Levy Antonin, Ammari Samy, Naltet Charles, Lavaud Pernelle, Aldea Mihaela, Vasseur Damien, Planchard David, Besse Benjamin |
| 659687 |
CANCER MANAGEMENT AND RESEARCH |
Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma |
2021-03-01 |
10.2147/cmar.s298412 |
Feng Ji-Feng, Zhao Jian-Ming, Chen Sheng, Chen Qi-Xun |
| 659686 |
CANCER MANAGEMENT AND RESEARCH |
The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer |
2021-03-01 |
10.2147/cmar.s299148 |
Abushamma Faris, Khayyat Zain, Soroghle Aya, Zyoud Sa’ed H, Jaradat Ahmad, Akkawi Maha, Aburass Hanood, Qaddumi Iyad KK, Odeh Razan, Salameh Husam, Albuheissi Salah |
| 659685 |
CANCER MANAGEMENT AND RESEARCH |
circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis |
2021-03-01 |
10.2147/cmar.s288229 |
Cao Guanghui, Zhang Chan, Tian Xiangyong, Jing Gaopeng, Zhou Xiaolin, Yan Tianzhong |
| 659684 |
CANCER MANAGEMENT AND RESEARCH |
Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer |
2021-03-01 |
10.2147/cmar.s300738 |
Zhang Nan, Yang Zhiyou, Jin Yue, Cheng Shanshan, Yang Jiani, Wang Yu |
| 659683 |
CANCER MANAGEMENT AND RESEARCH |
A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report |
2021-03-01 |
10.2147/cmar.s276799 |
Huang Yunke, Xu Jing, Li Ke, Wang Jing, Dai Yilin, Kang Yu |
| 659682 |
CANCER MANAGEMENT AND RESEARCH |
Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels |
2021-03-01 |
10.2147/cmar.s293005 |
Li Hongyan, Chen Xiaomin, Zhang Yajing, Wang Kun, Gao Zairong |
| 659681 |
CANCER MANAGEMENT AND RESEARCH |
Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma |
2021-03-01 |
10.2147/cmar.s296069 |
Jiang Jie, Liu Bin, Liu Ruilin, Yang Wenzhuo |
| 659680 |
CANCER MANAGEMENT AND RESEARCH |
WNT5a in Colorectal Cancer: Research Progress and Challenges |
2021-03-01 |
10.2147/cmar.s289819 |
Sun Guangshun, Wu Liangliang, Sun Guoqiang, Shi Xuesong, Cao Hongyong, Tang Weiwei |
| 659679 |
CANCER MANAGEMENT AND RESEARCH |
Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum] |
2021-03-01 |
10.2147/cmar.s310256 |
Li Xuguang, Chen Weirun, Liu Kaihang, Zhang Sheng, Yang Ru, Liu Kairui, Li Dateng, Huang Youxing |
